comparemela.com

Among CYP2C19 loss-of-function allele carriers with minor stroke or transient ischemic attack, those with normal renal function rather than impaired renal function derive greater benefit from ticagrelor-aspirin versus clopidogrel-aspirin.

Related Keywords

China ,Anxin Wang ,Salubris Pharmaceuticals ,Capital Medical University ,Healthday News ,Beijing Tiantan Hospital ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.